The following is a list of what is included in the item above. Click the test(s) below to view what biomarkers are measured along with an explanation of what the biomarker is measuring.
Also known as: K
Also known as: ZN, Plasma
The Nutrient Deficiency Panel for ACE Inhibitor Patients panel contains 2 tests with 2 biomarkers.
The Nutrient Deficiency Panel for ACE Inhibitor Patients is a targeted diagnostic tool designed to monitor the levels of specific nutrients that may be affected by the use of ACE inhibitors. ACE inhibitors (Angiotensin-Converting Enzyme inhibitors) are commonly prescribed medications for managing conditions such as hypertension, heart failure, and chronic kidney disease. These medications can impact the balance of certain electrolytes and trace minerals in the body, making it essential to monitor and address potential deficiencies to prevent adverse health effects.
This panel may be ordered for patients who are on long-term ACE inhibitor therapy, especially if they present symptoms indicative of electrolyte imbalance or trace mineral deficiencies. Common symptoms may include muscle weakness, fatigue, palpitations, and immune system dysfunction. It is also ordered as a part of routine monitoring in patients with cardiovascular or kidney conditions to ensure optimal management of their therapy and overall health.
The Nutrient Deficiency Panel for ACE Inhibitor Patients includes tests to measure the levels of essential nutrients impacted by ACE inhibitors:
The Nutrient Deficiency Panel for ACE Inhibitor Patients helps detect conditions associated with nutrient imbalances caused by ACE inhibitor therapy:
Healthcare professionals use the results of the Nutrient Deficiency Panel for ACE Inhibitor Patients to:
The Nutrient Deficiency Panel for ACE Inhibitor Patients is an essential diagnostic tool for monitoring and managing nutrient levels in individuals undergoing ACE inhibitor therapy. By evaluating potassium and zinc levels, this panel helps healthcare providers detect and address hyperkalemia and zinc deficiency, preventing potential complications and supporting overall health. Regular monitoring and timely interventions based on the test results ensure optimal management of therapy and enhance patient outcomes.